Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy

被引:23
|
作者
Furuichi, Kengo [1 ]
Shimizu, Miho [1 ]
Yuzawa, Yukio [2 ]
Hara, Akinori [1 ]
Toyama, Tadashi [1 ]
Kitamura, Hiroshi [3 ]
Suzuki, Yoshiki [4 ]
Sato, Hiroshi [5 ]
Uesugi, Noriko [6 ]
Ubara, Yoshifumi [7 ]
Hohino, Junichi [7 ]
Hisano, Satoshi [8 ]
Ueda, Yoshihiko [9 ]
Nishi, Shinichi [10 ,11 ]
Yokoyama, Hitoshi [12 ]
Nishino, Tomoya [13 ]
Kohagura, Kentaro [14 ]
Ogawa, Daisuke [15 ]
Mise, Koki [15 ]
Shibagaki, Yugo [16 ]
Makino, Hirofumi [15 ]
Matsuo, Seiichi [17 ]
Wada, Takashi [18 ]
机构
[1] Kanazawa Univ Hosp, Dept Nephrol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan
[2] Fujita Hlth Univ Hosp, Dept Nephrol, 1-98 Dengakugakubo Kutsukake Cho, Toyoake, Aichi 4701192, Japan
[3] Natl Hosp Org, Chiba East Natl Hosp, Clin Res Ctr, Dept Pathol, 673 Nitona, Chiba, Chiba 2608712, Japan
[4] Niigata Univ, Hlth Adm Ctr, Nishi Ku, 2-8085 Igarashi, Niigata, Niigata 9502181, Japan
[5] Tohoku Univ, Grad Sch Pharmaceut Sci, Clin Pharmacol & Therapeut, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan
[6] Univ Tsukuba, Fac Med, Dept Pathol, Tsukuba, Ibaraki, Japan
[7] Toranomon Gen Hosp, Nephrol Ctr, 2-2-2 Toranomon, Tokyo 1058470, Japan
[8] Fukuoka Univ, Fac Med, Dept Pathol, Fukuoka, Fukuoka, Japan
[9] Dokkyo Med Univ, Koshigaya Hosp, Dept Pathol, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan
[10] Kobe Univ, Grad Sch Med, Div Nephrol, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan
[11] Kobe Univ, Grad Sch Med, Kidney Ctr, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan
[12] Kanazawa Med Univ, Sch Med, Dept Nephrol, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan
[13] Nagasaki Univ, Sch Med, Dept Internal Med 2, 1-7-1 Sakamoto, Nagasaki 8528501, Japan
[14] Univ Ryukyus, Sch Med, Dept Cardiovasc Med Nephrol & Neurol, 207 Uehara,Nishihara Cho, Okinawa 9030215, Japan
[15] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan
[16] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan
[17] Nagoya Univ, Grad Sch Med, Dept Internal Med, Div Nephrol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan
[18] Kanazawa Univ, Dept Nephrol & Lab Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan
关键词
Japanese classification of diabetic nephropathy; Kidney biopsy; Nodular lesions; Mesangiolysis; Exudative lesions; Widening of the subendothelial space; JOINT COMMITTEE; KIDNEY-DISEASE; LESIONS; GLOMERULOSCLEROSIS; PREDICTORS; MELLITUS; OUTCOMES; DECLINE; IMPACT;
D O I
10.1007/s10157-017-1485-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The Japanese classification of diabetic nephropathy reflects the risks of mortality, cardiovascular events and kidney prognosis and is clinically useful. Furthermore, pathological findings of diabetic nephropathy are useful for predicting prognoses. In this study, we evaluated the characteristics of pathological findings in relation to the Japanese classification of diabetic nephropathy and their ability to predict prognosis. The clinical data of 600 biopsy-confirmed diabetic nephropathy patients were collected retrospectively from 13 centers across Japan. Composite kidney events, kidney death, cardiovascular events, all-cause mortality, and decreasing rate of estimated GFR (eGFR) were evaluated based on the Japanese classification of diabetic nephropathy. The median observation period was 70.4 (IQR 20.9-101.0) months. Each stage had specific characteristic pathological findings. Diffuse lesions, interstitial fibrosis and/or tubular atrophy (IFTA), interstitial cell infiltration, arteriolar hyalinosis, and intimal thickening were detected in more than half the cases, even in Stage 1. An analysis of the impacts on outcomes in all data showed that hazard ratios of diffuse lesions, widening of the subendothelial space, exudative lesions, mesangiolysis, IFTA, and interstitial cell infiltration were 2.7, 2.8, 2.7, 2.6, 3.5, and 3.7, respectively. Median declining speed of eGFR in all cases was 5.61 mL/min/1.73 m(2)/year, and the median rate of declining kidney function within 2 years after kidney biopsy was 24.0%. This study indicated that pathological findings could categorize the high-risk group as well as the Japanese classification of diabetic nephropathy. Further study using biopsy specimens is required to clarify the pathogenesis of diabetic kidney disease.
引用
收藏
页码:570 / 582
页数:13
相关论文
共 50 条
  • [31] The CNDP1 (CTG)5 Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration
    Albrecht, Thomas
    Zhang, Shiqi
    Braun, Jana D.
    Xia, Li
    Rodriquez, Angelica
    Qiu, Jiedong
    Peters, Verena
    Schmitt, Claus P.
    van den Born, Jacob
    Bakker, Stephan J. L.
    Lammert, Alexander
    Koeppel, Hannes
    Schnuelle, Peter
    Kraemer, Bernhard K.
    Yard, Benito A.
    Hauske, Sibylle J.
    [J]. JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [32] RENAL ARTERIOLAR HYALINOSIS, NOT INTIMAL THICKENING IN LARGER ARTERIES, IS ASSOCIATED WITH CARDIOVASCULAR EVENTS IN PATIENTS WITH BIOPSY-PROVEN DIABETIC NEPHROPATHY
    Morimoto, Katsuhiko
    Kokubu, Maiko
    Matsui, Masaru
    Fukata, Fumihiro
    Kanki, Tomoko
    Tagawa, Miho
    Samejima, Kenichi
    Akai, Yasuhiro
    Tsuruya, Kazuhiko
    Saito, Yoshihiko
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 495 - 496
  • [33] Renal arteriolar hyalinosis, not intimal thickening in large arteries, is associated with cardiovascular events in people with biopsy-proven diabetic nephropathy
    Morimoto, K.
    Matsui, M.
    Samejima, K.
    Kanki, T.
    Nishimoto, M.
    Tanabe, K.
    Murashima, M.
    Eriguchi, M.
    Akai, Y.
    Iwano, M.
    Shiiki, H.
    Yamada, H.
    Kanauchi, M.
    Dohi, K.
    Tsuruya, K.
    Saito, Y.
    [J]. DIABETIC MEDICINE, 2020, 37 (12) : 2143 - 2152
  • [34] Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy
    Wu, Chung-Ze
    Chang, Li-Chien
    Lin, Yuh-Feng
    Hung, Yi-Jen
    Pei, Dee
    Chu, Nain-Feng
    Chen, Jin-Shuen
    [J]. CLINICAL BIOCHEMISTRY, 2015, 48 (18) : 1324 - 1329
  • [35] Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease
    Wright, JR
    Duggal, A
    Thomas, R
    Reeve, R
    Roberts, ISD
    Kalra, PA
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (04) : 765 - 770
  • [36] Pathologic Classification of Diabetic Nephropathy
    Tervaert, Thijs W. Cohen
    Mooyaart, Antien L.
    Amann, Kerstin
    Cohen, Arthur H.
    Cook, H. Terence
    Drachenberg, Cinthia B.
    Ferrario, Franco
    Fogo, Agnes B.
    Haas, Mark
    de Heer, Emile
    Joh, Kensuke
    Noel, Laure H.
    Radhakrishnan, Jai
    Seshan, Surya V.
    Bajema, Ingeborg M.
    Bruijn, Jan A.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (04): : 556 - 563
  • [37] A low-cost laboratory-based method for predicting newly diagnosed biopsy-proven diabetic nephropathy in people with type 2 diabetes
    Yu, D.
    Shang, J.
    Cai, Y.
    Wang, Z.
    Zhao, B.
    Zhao, Z.
    Simmons, D.
    [J]. DIABETIC MEDICINE, 2020, 37 (10) : 1728 - 1736
  • [38] Severe 25-Hydroxyvitamin D Deficiency May Predict Poor Renal Outcomes in Patients With Biopsy-Proven Diabetic Nephropathy
    Zhou, Ting
    Shen, Li
    Li, Ze
    Jia, Junjie
    Xing, Haifan
    Wang, Niansong
    Jiao, Qiong
    Fan, Ying
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [39] Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
    Mise, Koki
    Yamaguchi, Yutaka
    Hoshino, Junichi
    Ueno, Toshiharu
    Sekine, Akinari
    Sumida, Keiichi
    Yamanouchi, Masayuki
    Hayami, Noriko
    Suwabe, Tatsuya
    Hiramatsu, Rikako
    Hasegawa, Eiko
    Sawa, Naoki
    Fujii, Takeshi
    Hara, Shigeko
    Sugiyama, Hitoshi
    Makino, Hirofumi
    Wada, Jun
    Ohashi, Kenichi
    Takaichi, Kenmei
    Ubara, Yoshifumi
    [J]. PLOS ONE, 2017, 12 (08):
  • [40] A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
    Masakazu Haneda
    Kazunori Utsunomiya
    Daisuke Koya
    Tetsuya Babazono
    Tatsumi Moriya
    Hirofumi Makino
    Kenjiro Kimura
    Yoshiki Suzuki
    Takashi Wada
    Susumu Ogawa
    Masaaki Inaba
    Yoshihiko Kanno
    Takashi Shigematsu
    Ikuto Masakane
    Ken Tsuchiya
    Keiko Honda
    Kazuko Ichikawa
    Kenichiro Shide
    [J]. Clinical and Experimental Nephrology, 2015, 19 : 1 - 5